PT Medikaloka Hermina Tbk(ID:HEAL)
Rp480.00-10.00 (-2.04%)
ID:HEAL
PT Medikaloka Hermina Tbk financials statements
Rp480.00
At close:-10.00 (-2.04%)
PT Medikaloka Hermina Tbk (HEAL) Ratios
PT Medikaloka Hermina Tbk Ratios
ID:HEAL's free cash flow for Q3 2026 was Rp174.86B. For the 2026 fiscal year, ID:HEAL's free cash flow was decreased by Rp-374.21B and operating cash flow was Rp549.07B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.22 | 1.13 | 1.26 | 1.05 | 1.52 |
| Quick Ratio | 1.13 | 1.05 | 1.18 | 0.99 | 1.47 |
| Cash Ratio | 0.38 | 0.35 | 0.55 | 0.45 | 0.80 |
| Solvency Ratio | 0.28 | 0.28 | 0.33 | 0.29 | 0.45 |
| Operating Cash Flow Ratio | 0.59 | 0.63 | 0.85 | 0.29 | 1.15 |
| Short-Term Operating Cash Flow Coverage | 1.96 | 2.82 | 5.17 | 0.88 | 9.81 |
| Net Current Asset Value | Rp -2.31T | Rp -2.66T | Rp -1.65T | Rp -1.12T | Rp -734.21B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.31 | 0.26 | 0.23 | 0.22 |
| Debt-to-Equity Ratio | 0.57 | 0.73 | 0.58 | 0.50 | 0.51 |
| Debt-to-Capital Ratio | 0.36 | 0.42 | 0.37 | 0.34 | 0.34 |
| Long-Term Debt-to-Capital Ratio | 0.32 | 0.39 | 0.34 | 0.25 | 0.31 |
| Financial Leverage Ratio | 2.09 | 2.38 | 2.28 | 2.21 | 2.32 |
| Debt Service Coverage Ratio | 2.04 | 2.83 | 3.63 | 1.51 | 5.62 |
| Interest Coverage Ratio | 3.95 | 5.91 | 5.59 | 4.20 | 12.42 |
| Debt to Market Cap | 0.15 | 0.13 | 0.10 | 0.08 | 0.11 |
| Interest Debt Per Share | 229.02 | 230.28 | 165.54 | 129.78 | 123.07 |
| Net Debt to EBITDA | 1.33 | 1.39 | 0.89 | 0.82 | 0.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.93% | 36.45% | 31.54% | 34.85% | 49.75% |
| EBIT Margin | 13.92% | 16.12% | 14.69% | 12.65% | 30.75% |
| EBITDA Margin | 26.27% | 27.69% | 27.39% | 23.96% | 38.23% |
| Operating Profit Margin | 13.20% | 15.71% | 13.50% | 11.98% | 30.55% |
| Pretax Profit Margin | 10.58% | 13.47% | 12.28% | 9.79% | 28.49% |
| Net Profit Margin | 6.02% | 7.96% | 7.56% | 6.09% | 17.11% |
| Continuous Operations Profit Margin | 7.70% | 10.23% | 9.67% | 7.73% | 22.18% |
| Net Income Per EBT | 56.90% | 59.08% | 61.56% | 62.20% | 60.06% |
| EBT Per EBIT | 80.19% | 85.72% | 90.99% | 81.73% | 93.25% |
| Return on Assets (ROA) | 3.61% | 5.07% | 4.97% | 3.93% | 13.13% |
| Return on Equity (ROE) | 7.57% | 12.04% | 11.30% | 8.68% | 30.47% |
| Return on Capital Employed (ROCE) | 9.46% | 12.08% | 10.77% | 9.99% | 29.79% |
| Return on Invested Capital (ROIC) | 6.50% | 8.77% | 8.19% | 7.18% | 22.62% |
| Return on Tangible Assets | 3.62% | 5.07% | 4.97% | 3.93% | 13.13% |
| Earnings Yield | 2.07% | 2.22% | 2.02% | 1.33% | 6.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.04 | 5.38 | 6.01 | 5.46 | 5.43 |
| Payables Turnover | 10.76 | 9.89 | 11.13 | 11.34 | 9.02 |
| Inventory Turnover | 29.59 | 31.02 | 33.72 | 31.92 | 30.90 |
| Fixed Asset Turnover | 0.77 | 0.83 | 0.89 | 0.89 | 1.19 |
| Asset Turnover | 0.60 | 0.64 | 0.66 | 0.65 | 0.77 |
| Working Capital Turnover Ratio | 21.74 | 21.53 | 24.21 | 10.55 | 7.18 |
| Cash Conversion Cycle | 50.84 | 42.64 | 38.80 | 46.13 | 38.54 |
| Days of Sales Outstanding | 72.42 | 67.79 | 60.77 | 66.90 | 67.21 |
| Days of Inventory Outstanding | 12.34 | 11.77 | 10.82 | 11.43 | 11.81 |
| Days of Payables Outstanding | 33.91 | 36.92 | 32.79 | 32.20 | 40.48 |
| Operating Cycle | 84.76 | 79.56 | 71.59 | 78.33 | 79.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 75.23 | 76.65 | 91.00 | 34.82 | 126.24 |
| Free Cash Flow Per Share | -40.47 | -77.10 | -18.74 | -43.24 | 43.71 |
| Dividend Paid and CapEx Coverage Ratio | 0.60 | 0.47 | 0.78 | 0.41 | 1.44 |
| Capital Expenditure Coverage Ratio | 0.65 | 0.50 | 0.83 | 0.45 | 1.53 |
| Operating Cash Flow Coverage Ratio | 0.35 | 0.35 | 0.58 | 0.29 | 1.11 |
| Operating Cash Flow to Sales Ratio | 0.16 | 0.17 | 0.23 | 0.10 | 0.32 |
| Free Cash Flow Yield | -2.94% | -4.73% | -1.26% | -2.79% | 4.09% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 48.42 | 45.37 | 49.40 | 75.10 | 15.80 |
| Price-to-Sales (P/S) Ratio | 2.92 | 3.59 | 3.74 | 4.57 | 2.70 |
| Price-to-Book (P/B) Ratio | 3.66 | 5.43 | 5.58 | 6.52 | 4.81 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -33.97 | -21.14 | -79.52 | -35.85 | 24.48 |
| Price-to-Operating Cash Flow Ratio | 18.28 | 21.27 | 16.37 | 44.52 | 8.48 |
| Price-to-Earnings Growth (PEG) Ratio | -2.31 | 2.37 | 1.07 | -1.08 | 0.28 |
| Enterprise Value Multiple | 12.43 | 14.36 | 14.52 | 19.91 | 7.24 |
| Enterprise Value | 23.29T | 26.79T | 23.01T | 23.38T | 16.11T |
| EV to EBITDA | 12.43 | 14.36 | 14.52 | 19.91 | 7.24 |
| EV to Sales | 3.27 | 3.98 | 3.98 | 4.77 | 2.77 |
| EV to Free Cash Flow | -38.05 | -23.41 | -84.69 | -37.39 | 25.07 |
| EV to Operating Cash Flow | 20.47 | 23.55 | 17.44 | 46.43 | 8.68 |
| Tangible Book Value Per Share | 475.87 | 395.25 | 358.48 | 323.93 | 298.29 |
| Shareholders’ Equity Per Share | 375.33 | 299.96 | 266.82 | 237.88 | 222.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.24 | 0.21 | 0.21 | 0.22 |
| Revenue Per Share | 471.66 | 453.90 | 398.88 | 338.89 | 395.80 |
| Net Income Per Share | 28.40 | 36.11 | 30.16 | 20.64 | 67.73 |
| Tax Burden | 0.57 | 0.59 | 0.62 | 0.62 | 0.60 |
| Interest Burden | 0.76 | 0.84 | 0.84 | 0.77 | 0.93 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.03 | 0.03 | 0.05 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.65 | 2.12 | 3.02 | 1.33 | 1.86 |
Currency in IDR
